Literature DB >> 30788015

Prediabetes: Why Should We Care?

Ashkan Zand1, Karim Ibrahim1, Bhargavi Patham1.   

Abstract

A clear link between cardiovascular disease and prediabetes has emerged over the past few years. Recent studies have shown that patients with prediabetes can suffer from coronary artery disease and diastolic heart failure even before progressing to overt diabetes. With this knowledge, physicians must identify prediabetes and take appropriate measures to optimize glycemic control. The pathophysiological defect seen in prediabetes can be managed with lifestyle modifications; thus, it is essential that physicians have a clear understanding of the current recommendations regarding diet and exercise. This review outlines the complications associated with prediabetes, presents an overview of the available pharmacological and surgical therapies that are effective in treating it, and provides a stepwise, multipronged approach for management.

Entities:  

Keywords:  diabetes prevention; impaired fasting glucose; impaired glucose tolerance; management of prediabetes; prediabetes

Mesh:

Substances:

Year:  2018        PMID: 30788015      PMCID: PMC6369626          DOI: 10.14797/mdcj-14-4-289

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  13 in total

1.  Prediabetes Deserves More Attention: A Review.

Authors:  Yakubu Lawal; Fatima Bello; Yazid Suleiman Kaoje
Journal:  Clin Diabetes       Date:  2020-10

2.  Predictive Efficiency of Prediabetes for Diabetes Among Chinese Middle-Aged and Older Populations: a 5-Year National Prospective Cohort Study.

Authors:  Hang Sun; Lu Xu; Lili Liu; Siyan Zhan; Shengfeng Wang; Yongfeng Song
Journal:  J Gen Intern Med       Date:  2022-07-11       Impact factor: 6.473

Review 3.  The effects of cannabis and cannabinoids on the endocrine system.

Authors:  Farah Meah; Michelle Lundholm; Nicholas Emanuele; Hafsa Amjed; Caroline Poku; Lily Agrawal; Mary Ann Emanuele
Journal:  Rev Endocr Metab Disord       Date:  2021-08-30       Impact factor: 9.306

Review 4.  The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum indicum: A Systematic Review.

Authors:  Nik Nur Hakimah Nik Salleh; Farah Amna Othman; Nur Alisa Kamarudin; Suat Cheng Tan
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

5.  Time to Development of Overt Diabetes and Macrovascular and Microvascular Complications Among Patients With Prediabetes: A Retrospective Cohort Study.

Authors:  Tyler Finocchio; Satya Surbhi; Charisse Madlock-Brown
Journal:  Cureus       Date:  2021-12-01

6.  Incidence and Risk Factors for Progression to Diabetes Mellitus: A Retrospective Cohort Study.

Authors:  Min Kyung Hyun; Jong Heon Park; Kyoung Hoon Kim; Soon-Ki Ahn; Seon Mi Ji
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390

7.  Related Factors for Impaired Fasting Glucose in Korean Adults: A Population Based Study.

Authors:  Hyunjin Lee; Bohyun Kim; Youngshin Song
Journal:  BMC Public Health       Date:  2021-12-11       Impact factor: 3.295

8.  Cardiac miRNA Expression and their mRNA Targets in a Rat Model of Prediabetes.

Authors:  Éva Sághy; Imre Vörös; Bence Ágg; Bernadett Kiss; Gábor Koncsos; Zoltán V Varga; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

9.  Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.

Authors:  Miquel Bennasar-Veny; Sergio Fresneda; Arturo López-González; Carla Busquets-Cortés; Antoni Aguiló; Aina M Yañez
Journal:  Nutrients       Date:  2020-05-25       Impact factor: 5.717

10.  Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.

Authors:  Richard E Pratley; Stephan Jacob; Seungjae Baek; Michael E Trautmann; Marcus Hompesch; OakPil Han; John Stewart; Christopher H Sorli; Alka Shaunik; Kun-Ho Yoon
Journal:  BMJ Open Diabetes Res Care       Date:  2022-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.